Vijaykrishna Raghunathan, University of Houston (IMAGE)

University of Houston

Vijaykrishna Raghunathan, University of Houston

Caption

With $765,000 from the National Institutes of Health, University of Houston College of Optometry biomedical engineer Vijaykrishna Raghunathan is working towards a pharmaceutical cure for the irreversible disease Glaucoma.

Credit

University of Houston

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.